New COVID Shots Same As Old Ones
Two studies performed recently at Columbia University and Harvard University have found that the new COVID-19 bivalent (two-in-one) booster shots developed by Pfizer/BioNTech and Moderna/NIAID do not provide better protection against the BA.4 and BA.5 Omicron subvariant viruses than the original monovalent formulations of the shots.1 2 3 In the Columbia study, 19 people were […]
FDA Authorizes COVID Bivalent Shots for Children as Young as Five Years Old
On Oct. 12, 2022, the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) of the COVID bivalent booster versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID for children as young as five or six years old, respectively. The FDA’s decision on Aug. 31 to grant […]
Getting a Flu Shot and COVID Bivalent Booster Together
Despite President Biden’s recent admission that the COVID-19 pandemic is over, the White House is making another big push to encourage Americans to get yet another COVID booster shot. This time, the Biden administration is marketing the COVID Bivalent versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID respectively.1 2 […]
Safety and Effectiveness of New COVID Bivalent Boosters Based on a Study of Eight Mice?
With no safety and efficacy evidence from human clinical trials, on Aug. 31, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for Pfizer/BioNTech’s Comirnaty and Moderna/NIAID’s Spikevax messenger RNA (mRNA) COVID-19 biologics to distribute “bivalent formulations” (two-in-one) of the shots to use as a “single booster dose.”1 2 The […]
Doctor in India Sues Government Over COVID-19 Vaccine
Jacob Puliyel, MD, a pediatrician in India for more than 40 years, brought suit in the Supreme Court of India against the Union of India and COVID-19 vaccine manufacturers in a legal challenge to the country’s COVID vaccine program.1 Dr. Puliyel, who has served as Director of Research and Projects at Holy Family Hospital in Delhi […]
Paxlovid Users May Face Rebound SARS-CoV-2
The U.S. Centers for Disease Control and Prevention (CDC) has admitted that COVID-19 patients may experience a rebound SARS-CoV-2 infection after taking Pfizer’s antiviral drug, Paxlovid. Evidence has shown that patients, including those who have gotten COVID shots and been boosted, may suffer a reoccurrence of COVID two to eight days after completing a five-day […]